CRVO vs MAS · $28.8M cap vs P/E 18, rev $7.56B
CervoMed Inc. (CRVO) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
CervoMed Inc. (CRVO) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported CRVO revenue for 2026-06-30 was $0. Net income was -$14.5M. CRVO currently screens at market cap $28.8M.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
CRVO currently screens at market cap $28.8M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the CRVO and MAS stock pages for the full models.
Not investment advice.